<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="105968">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02001662</url>
  </required_header>
  <id_info>
    <org_study_id>SM3-ME-13</org_study_id>
    <secondary_id>2013-000663-83</secondary_id>
    <secondary_id>H-3-2013-039</secondary_id>
    <nct_id>NCT02001662</nct_id>
  </id_info>
  <brief_title>Adductor Canal Block and Arthroscopic Knee Surgery, High Pain Responders</brief_title>
  <official_title>The Analgesic Efficacy of the Adductor Canal Blockade in High Pain Responders After Arthroscopic Knee Surgery - a Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Glostrup University Hospital, Copenhagen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Glostrup University Hospital, Copenhagen</source>
  <oversight_info>
    <authority>Denmark: Danish Health and Medicines Authority</authority>
    <authority>Denmark: The Committees on Biomedical Research Ethics for the Capital Region of Denmark</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators want to explore the analgesic effect of Adductor Canal Blockade (a
      peripheral nerve block) in high pain responding patients after arthroscopic knee surgery.
      The investigators hypothesize that the nerve block will have an abrupt analgesic effect.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2013</start_date>
  <completion_date type="Actual">November 2013</completion_date>
  <primary_completion_date type="Actual">November 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Pain score during 45 degree flexion of the knee</measure>
    <time_frame>45 minutes after nerve block</time_frame>
    <safety_issue>No</safety_issue>
    <description>Pain score during flexion of the knee 45 min. after nerve block</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain score</measure>
    <time_frame>0-90 min. after first nerveblock</time_frame>
    <safety_issue>No</safety_issue>
    <description>pain score at rest: time 0,15,30,45,60,75,90 min. after first nerve block pain score during flexion of the knee: time 0,15,30,45,60,75,90 min. after first nerve block pain score during mobilisation (5m walk): 45 and 90 min after nerve block</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>muscle strength</measure>
    <time_frame>45 and 90 min after nerve block</time_frame>
    <safety_issue>No</safety_issue>
    <description>patients accesses muscle strength during walk</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Opioid consumption</measure>
    <time_frame>0-90 min after nerve block</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Arthroscopic Knee Surgery</condition>
  <arm_group>
    <arm_group_label>Intervention group, block no. 1 - Ropivacain</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Adductor-Canal-Block no.1: 30mL ropivacaine (7.5 mg/ml) when postoperative VAS-score is &gt; 40mm (on a 0-100 mm VAS-scale) during a 45 degree active flexion of the knee.
Adductor-Canal-Block no.2: after 45 min (t45) - 30mL isotonic saline.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group, block no. 1 - saline</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Adductor-Canal-Block no.1: 30mL isotonic saline when postoperative VAS-score is above 40mm (on a 0-100 mm VAS-scale) during a 45 degree active flexion of the knee.
Adductor-Canal-Block no.2: after 45 min (t45) - 30mL ropivacaine (7.5 mg/ml)</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Intervention group, block no. 1 - Ropivacain</intervention_name>
    <description>Intervention group: 1. block ropivacaine - 2. block saline</description>
    <arm_group_label>Intervention group, block no. 1 - Ropivacain</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Control group: 1. block - saline</intervention_name>
    <description>Control group: 1. block saline - 2. block ropivacaine</description>
    <arm_group_label>Control group, block no. 1 - saline</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Arthroscopic knee surgery, if reconstruction of Anterior Cruciate Ligament only hamstring
        graft 18-80 years of age BMI 18-40 ASA I-III written Consent

        Exclusion Criteria:

        Unable to communicate in danish, allergic reactions toward any study medication pregnancy
        alcohol/drug abuse daily opioid consumption scin infection (injection site)
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Malene Espelund, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Glostrup University Hospital, University of Copenhagen</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Amager Hospital, University of Copenhagen, Denmark</name>
      <address>
        <city>Copenhagen</city>
        <state>Copenhagen, Amager</state>
        <zip>2300</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <lastchanged_date>December 5, 2013</lastchanged_date>
  <firstreceived_date>April 9, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Glostrup University Hospital, Copenhagen</investigator_affiliation>
    <investigator_full_name>Malene Espelund</investigator_full_name>
    <investigator_title>MD,</investigator_title>
  </responsible_party>
  <keyword>Minor arthroscopic knee surgery including ACL-reconstruction (hamstrins graft)</keyword>
  <keyword>High pain responders</keyword>
  <keyword>Adductore Canal Block</keyword>
  <keyword>Analgesics</keyword>
  <keyword>Ultrasound guided nerve block</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Analgesics</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
